Ikeda Norihiko, Hayashi Aeru, Iwasaki Kentaro, Honda Hidetoshi, Tsuboi Masahiro, Usuda Jitsuo, Kato Harubumi
Department of Thoracic Oncology and Surgery, International University of Health and Welfare, Mita Hospital, Japan.
Lung Cancer. 2007 Jun;56(3):295-302. doi: 10.1016/j.lungcan.2007.01.009. Epub 2007 Feb 8.
Due to advances in interventional bronchoscopy, curative treatment has become possible for central type lung cancer if it is detected in the early stage. However, expertise is required to diagnose the extent of tumor invasion and the depth of tumor involvement by conventional white light bronchoscopy alone, but judgement is still subjective. The development of autofluorescence bronchoscopy (AFB) and endobronchial ultrasonography (EBUS) has had a large impact on diagnostic bronchoscopy in the past decade and have been employed especially for the diagnosis of central type tumors. Objective evaluation by a comprehensive approach using AFB, EBUS and optical coherence tomography (OCT) enables selection of the optimal therapeutic strategy for central type early lung cancer (CELC).
由于介入性支气管镜检查技术的进步,如果早期发现中央型肺癌,根治性治疗已成为可能。然而,仅通过传统白光支气管镜检查来诊断肿瘤浸润范围和肿瘤累及深度需要专业知识,而且判断仍然主观。在过去十年中,自发荧光支气管镜检查(AFB)和支气管内超声检查(EBUS)的发展对诊断性支气管镜检查产生了重大影响,尤其被用于中央型肿瘤的诊断。通过综合运用AFB、EBUS和光学相干断层扫描(OCT)进行客观评估,能够为中央型早期肺癌(CELC)选择最佳治疗策略。